Loading provider…
Loading provider…
Neurological Surgery Physician in Los Angeles, CA
NPI: 1144543455Primary Employer
Roswell Park Cancer Institute
roswellpark.org
HQ Phone
Get MD Andrew's Phone Numberphone_androidMobile
Get MD Andrew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2005 - 2027

American Board of Neurological Surgery
Neurological Surgery
University at Buffalo
Residency • Neurological Surgery
2004 - 2010
Jacobs School of Medicine and Biomedical Sciences
medicine.buffalo.edu
Medical School
Until 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 61796Stereotactic treatment of brain growth | 26 | 31 |
| 2 | 61797Stereotactic treatment of brain growth | 19 | 52 |
Preoperative Predictors for Improvement after Surgical Untethering in Occult Tight Filum Terminale Syndrome
Authors: Andrew J. Fabiano, Mohammed F. Khan, Curtis J. Rozzelle, Veetai Li
Publication Date: 2009-07
Post-stereotactic radiosurgery brain metastases: a review.
Authors: Fabiano, A J, Qiu, J
Journal: J Neurosurg Sci
Publication Date: 2015-01-20
Muir-Torre Syndrome and Central Nervous System Malignancy: Highlighting an Uncommon Association.
Authors: Jacqueline Watchmaker
Journal: Dermatol Surg
Lead Sponsor: Arbor Pharmaceuticals, Inc.
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: Genentech, Inc., National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: bevacizumab, DRUG: corticosteroids
Lead Sponsor: Roswell Park Cancer Institute
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Sargramostim, DRUG: Montanide ISA 51 VG, BIOLOGICAL: SVN53-67/M57-KLH Peptide Vaccine